Defining new reference intervals for serum free light chains in individuals with chronic kidney disease : Results of the iStopMM study
Funding Information: Dr. Landgren has received grant support from: NCI/NIH, FDA, LLS, Rising Tide Foundation, Memorial Sloan Kettering Cancer Center, MMRF, IMF, Paula, and Rodger Riney Foundation, Perelman Family Foundation, Amgen, Celgene, Janssen, Takeda, Glenmark, Seattle Genetics, Karyopharm; ha...
Published in: | Blood Cancer Journal |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
Other Authors: | , , , , , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
2022
|
Subjects: | |
Online Access: | https://hdl.handle.net/20.500.11815/3484 https://doi.org/10.1038/s41408-022-00732-3 |
id |
ftopinvisindi:oai:opinvisindi.is:20.500.11815/3484 |
---|---|
record_format |
openpolar |
institution |
Open Polar |
collection |
Opin vísindi (Iceland) |
op_collection_id |
ftopinvisindi |
language |
English |
topic |
Lífefna- og sameindalíffræði Blóðlæknisfræði Myndgreining (læknisfræði) Nýrnalæknisfræði Meinafræði Gigtarlæknisfræði Humans Immunoglobulin Light Chains Immunoglobulin lambda-Chains Prospective Studies Reference Values Renal Insufficiency Chronic/diagnosis Hematology Oncology |
spellingShingle |
Lífefna- og sameindalíffræði Blóðlæknisfræði Myndgreining (læknisfræði) Nýrnalæknisfræði Meinafræði Gigtarlæknisfræði Humans Immunoglobulin Light Chains Immunoglobulin lambda-Chains Prospective Studies Reference Values Renal Insufficiency Chronic/diagnosis Hematology Oncology Long, Þórir Einarsson Indriðason, Ólafur Skúli Pálsson, Runólfur Rögnvaldsson, Sæmundur Löve, Þorvarður Jón Thorsteinsdóttir, Sigrún Sverrisdóttir, Ingigerður S Viðarsson, Brynjar Önundarson, Páll Torfi Agnarsson, Bjarni Agnar Sigurðardóttir, Margrét Þorsteinsdóttir, Ingunn Ólafsson, Ísleifur Thordardottir, Asdis Rosa Eyþórsson, Elías Sæbjörn Jónsson, Ásbjörn Gíslason, Gauti Kjartan Ólafsson, Andri Steingrímsdóttir, Hlíf Hultcrantz, Malin Durie, Brian G.M. Harding, Stephen Landgren, Ola Kristinsson, Sigurður Yngvi Defining new reference intervals for serum free light chains in individuals with chronic kidney disease : Results of the iStopMM study |
topic_facet |
Lífefna- og sameindalíffræði Blóðlæknisfræði Myndgreining (læknisfræði) Nýrnalæknisfræði Meinafræði Gigtarlæknisfræði Humans Immunoglobulin Light Chains Immunoglobulin lambda-Chains Prospective Studies Reference Values Renal Insufficiency Chronic/diagnosis Hematology Oncology |
description |
Funding Information: Dr. Landgren has received grant support from: NCI/NIH, FDA, LLS, Rising Tide Foundation, Memorial Sloan Kettering Cancer Center, MMRF, IMF, Paula, and Rodger Riney Foundation, Perelman Family Foundation, Amgen, Celgene, Janssen, Takeda, Glenmark, Seattle Genetics, Karyopharm; has received honoraria for scientific talks/participated in advisory boards for: Adaptive, Amgen, Binding Site, BMS, Celgene, Cellectis, Glenmark, Janssen, Juno, Pfizer; and served on Independent Data Monitoring Committees (IDMC) for international randomized trials by: Takeda, Merck, Janssen, Theradex. Dr. Hultcrantz has recevied grant support from GSK, Amgen, Daiichi Sankyo, Cosette Pharmaceuticals, and has received honoraria for scientific talks/participated in advisory boards for BMS, Curio Science, and Intellisphere LLC. All other authors declare no potential conflicts of interest. Funding Information: Dr. Kristinsson has received research funding from International Myeloma Foundation, European Research Council, Icelandic Center for Research (Rannís), Amgen, Celgene. Dr. Long has received research funding from the Icelandic Center for Research (Rannís). Dr. Landgren thanks Sylvester Comprehensive Cancer Center Core Grant (P30 CA240139) and Paula and Rodger Riney Foundation for support of his research. Dr. Hultcrantz thanks the Memorial Sloan Kettering Cancer Center Core Grant (P30 CA008748). The iStopMM study is funded by the Black Swan Research Initiative by the International Myeloma Foundation, the European Research Council, and the Icelandic Center for Research. Screening tests for the iStopMM study are performed by The Binding Site Ltd. Birmingham, UK. Additional funding is provided by the University of Iceland, Landspitali–The National University Hospital, and the Icelandic Cancer Society. Funding Information: Dr. Kristinsson has received research funding from International Myeloma Foundation, European Research Council, Icelandic Center for Research (Rannís), Amgen, Celgene. Dr. Long has received research ... |
author2 |
Internal Medicine and Emergency Services Other departments Faculty of Medicine Clinical Laboratory Services, Diagnostics and Blood Bank Office of Division of Clinical Services II Cancer Center University of Iceland Landspitali - The National University Hospital of Iceland |
format |
Article in Journal/Newspaper |
author |
Long, Þórir Einarsson Indriðason, Ólafur Skúli Pálsson, Runólfur Rögnvaldsson, Sæmundur Löve, Þorvarður Jón Thorsteinsdóttir, Sigrún Sverrisdóttir, Ingigerður S Viðarsson, Brynjar Önundarson, Páll Torfi Agnarsson, Bjarni Agnar Sigurðardóttir, Margrét Þorsteinsdóttir, Ingunn Ólafsson, Ísleifur Thordardottir, Asdis Rosa Eyþórsson, Elías Sæbjörn Jónsson, Ásbjörn Gíslason, Gauti Kjartan Ólafsson, Andri Steingrímsdóttir, Hlíf Hultcrantz, Malin Durie, Brian G.M. Harding, Stephen Landgren, Ola Kristinsson, Sigurður Yngvi |
author_facet |
Long, Þórir Einarsson Indriðason, Ólafur Skúli Pálsson, Runólfur Rögnvaldsson, Sæmundur Löve, Þorvarður Jón Thorsteinsdóttir, Sigrún Sverrisdóttir, Ingigerður S Viðarsson, Brynjar Önundarson, Páll Torfi Agnarsson, Bjarni Agnar Sigurðardóttir, Margrét Þorsteinsdóttir, Ingunn Ólafsson, Ísleifur Thordardottir, Asdis Rosa Eyþórsson, Elías Sæbjörn Jónsson, Ásbjörn Gíslason, Gauti Kjartan Ólafsson, Andri Steingrímsdóttir, Hlíf Hultcrantz, Malin Durie, Brian G.M. Harding, Stephen Landgren, Ola Kristinsson, Sigurður Yngvi |
author_sort |
Long, Þórir Einarsson |
title |
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease : Results of the iStopMM study |
title_short |
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease : Results of the iStopMM study |
title_full |
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease : Results of the iStopMM study |
title_fullStr |
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease : Results of the iStopMM study |
title_full_unstemmed |
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease : Results of the iStopMM study |
title_sort |
defining new reference intervals for serum free light chains in individuals with chronic kidney disease : results of the istopmm study |
publishDate |
2022 |
url |
https://hdl.handle.net/20.500.11815/3484 https://doi.org/10.1038/s41408-022-00732-3 |
long_lat |
ENVELOPE(-62.983,-62.983,-64.300,-64.300) ENVELOPE(-83.567,-83.567,-79.700,-79.700) |
geographic |
Lambda Rodger |
geographic_facet |
Lambda Rodger |
genre |
Iceland |
genre_facet |
Iceland |
op_relation |
Blood Cancer Journal; 12(9) http://www.scopus.com/inward/record.url?scp=85137808095&partnerID=8YFLogxK Long , Þ E , Indriðason , Ó S , Pálsson , R , Rögnvaldsson , S , Löve , Þ J , Thorsteinsdóttir , S , Sverrisdóttir , I S , Viðarsson , B , Önundarson , P T , Agnarsson , B A , Sigurðardóttir , M , Þorsteinsdóttir , I , Ólafsson , Í , Thordardottir , A R , Eyþórsson , E S , Jónsson , Á , Gíslason , G K , Ólafsson , A , Steingrímsdóttir , H , Hultcrantz , M , Durie , B G M , Harding , S , Landgren , O & Kristinsson , S Y 2022 , ' Defining new reference intervals for serum free light chains in individuals with chronic kidney disease : Results of the iStopMM study ' , Blood Cancer Journal , vol. 12 , no. 9 , 133 , pp. 133 . https://doi.org/10.1038/s41408-022-00732-3 2044-5385 60192321 6890b99d-f5c6-44a2-848b-c3d0bea04d28 85137808095 36100605 https://hdl.handle.net/20.500.11815/3484 doi:10.1038/s41408-022-00732-3 |
op_rights |
info:eu-repo/semantics/openAccess |
op_doi |
https://doi.org/20.500.11815/348410.1038/s41408-022-00732-3 |
container_title |
Blood Cancer Journal |
container_volume |
12 |
container_issue |
9 |
_version_ |
1782335942123585536 |
spelling |
ftopinvisindi:oai:opinvisindi.is:20.500.11815/3484 2023-11-12T04:19:33+01:00 Defining new reference intervals for serum free light chains in individuals with chronic kidney disease : Results of the iStopMM study Long, Þórir Einarsson Indriðason, Ólafur Skúli Pálsson, Runólfur Rögnvaldsson, Sæmundur Löve, Þorvarður Jón Thorsteinsdóttir, Sigrún Sverrisdóttir, Ingigerður S Viðarsson, Brynjar Önundarson, Páll Torfi Agnarsson, Bjarni Agnar Sigurðardóttir, Margrét Þorsteinsdóttir, Ingunn Ólafsson, Ísleifur Thordardottir, Asdis Rosa Eyþórsson, Elías Sæbjörn Jónsson, Ásbjörn Gíslason, Gauti Kjartan Ólafsson, Andri Steingrímsdóttir, Hlíf Hultcrantz, Malin Durie, Brian G.M. Harding, Stephen Landgren, Ola Kristinsson, Sigurður Yngvi Internal Medicine and Emergency Services Other departments Faculty of Medicine Clinical Laboratory Services, Diagnostics and Blood Bank Office of Division of Clinical Services II Cancer Center University of Iceland Landspitali - The National University Hospital of Iceland 2022-09-14 1 1364270 133 https://hdl.handle.net/20.500.11815/3484 https://doi.org/10.1038/s41408-022-00732-3 en eng Blood Cancer Journal; 12(9) http://www.scopus.com/inward/record.url?scp=85137808095&partnerID=8YFLogxK Long , Þ E , Indriðason , Ó S , Pálsson , R , Rögnvaldsson , S , Löve , Þ J , Thorsteinsdóttir , S , Sverrisdóttir , I S , Viðarsson , B , Önundarson , P T , Agnarsson , B A , Sigurðardóttir , M , Þorsteinsdóttir , I , Ólafsson , Í , Thordardottir , A R , Eyþórsson , E S , Jónsson , Á , Gíslason , G K , Ólafsson , A , Steingrímsdóttir , H , Hultcrantz , M , Durie , B G M , Harding , S , Landgren , O & Kristinsson , S Y 2022 , ' Defining new reference intervals for serum free light chains in individuals with chronic kidney disease : Results of the iStopMM study ' , Blood Cancer Journal , vol. 12 , no. 9 , 133 , pp. 133 . https://doi.org/10.1038/s41408-022-00732-3 2044-5385 60192321 6890b99d-f5c6-44a2-848b-c3d0bea04d28 85137808095 36100605 https://hdl.handle.net/20.500.11815/3484 doi:10.1038/s41408-022-00732-3 info:eu-repo/semantics/openAccess Lífefna- og sameindalíffræði Blóðlæknisfræði Myndgreining (læknisfræði) Nýrnalæknisfræði Meinafræði Gigtarlæknisfræði Humans Immunoglobulin Light Chains Immunoglobulin lambda-Chains Prospective Studies Reference Values Renal Insufficiency Chronic/diagnosis Hematology Oncology /dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article 2022 ftopinvisindi https://doi.org/20.500.11815/348410.1038/s41408-022-00732-3 2023-11-01T23:55:22Z Funding Information: Dr. Landgren has received grant support from: NCI/NIH, FDA, LLS, Rising Tide Foundation, Memorial Sloan Kettering Cancer Center, MMRF, IMF, Paula, and Rodger Riney Foundation, Perelman Family Foundation, Amgen, Celgene, Janssen, Takeda, Glenmark, Seattle Genetics, Karyopharm; has received honoraria for scientific talks/participated in advisory boards for: Adaptive, Amgen, Binding Site, BMS, Celgene, Cellectis, Glenmark, Janssen, Juno, Pfizer; and served on Independent Data Monitoring Committees (IDMC) for international randomized trials by: Takeda, Merck, Janssen, Theradex. Dr. Hultcrantz has recevied grant support from GSK, Amgen, Daiichi Sankyo, Cosette Pharmaceuticals, and has received honoraria for scientific talks/participated in advisory boards for BMS, Curio Science, and Intellisphere LLC. All other authors declare no potential conflicts of interest. Funding Information: Dr. Kristinsson has received research funding from International Myeloma Foundation, European Research Council, Icelandic Center for Research (Rannís), Amgen, Celgene. Dr. Long has received research funding from the Icelandic Center for Research (Rannís). Dr. Landgren thanks Sylvester Comprehensive Cancer Center Core Grant (P30 CA240139) and Paula and Rodger Riney Foundation for support of his research. Dr. Hultcrantz thanks the Memorial Sloan Kettering Cancer Center Core Grant (P30 CA008748). The iStopMM study is funded by the Black Swan Research Initiative by the International Myeloma Foundation, the European Research Council, and the Icelandic Center for Research. Screening tests for the iStopMM study are performed by The Binding Site Ltd. Birmingham, UK. Additional funding is provided by the University of Iceland, Landspitali–The National University Hospital, and the Icelandic Cancer Society. Funding Information: Dr. Kristinsson has received research funding from International Myeloma Foundation, European Research Council, Icelandic Center for Research (Rannís), Amgen, Celgene. Dr. Long has received research ... Article in Journal/Newspaper Iceland Opin vísindi (Iceland) Lambda ENVELOPE(-62.983,-62.983,-64.300,-64.300) Rodger ENVELOPE(-83.567,-83.567,-79.700,-79.700) Blood Cancer Journal 12 9 |